150 related articles for article (PubMed ID: 9486557)
1. Prostate-specific antigen or human kallikrein 3? Recent developments.
Diamandis EP
Tumour Biol; 1998; 19(2):65-7; discussion 67-8. PubMed ID: 9486557
[No Abstract] [Full Text] [Related]
2. Prostate detection possibility.
Gunby P
JAMA; 1999 Jun 23-30; 281(24):2274-5. PubMed ID: 10386541
[No Abstract] [Full Text] [Related]
3. [Prostate Specific Antigen (PSA), yet how much damage?].
Braillon A; Hill C; Dubois G
Presse Med; 2012 May; 41(5):482-5. PubMed ID: 22336482
[TBL] [Abstract][Full Text] [Related]
4. Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy Subgroups.
Vickers AJ; Vertosick EA; Sjoberg DD
Eur Urol; 2018 Oct; 74(4):535-536. PubMed ID: 29903434
[No Abstract] [Full Text] [Related]
5. Prostate-specific antigen (hK3) and human prostatic glandular kallikrein (hK2) in the detection of early stage human prostate cancer.
Wilson MJ
J Lab Clin Med; 1998 Apr; 131(4):298-9. PubMed ID: 9579381
[No Abstract] [Full Text] [Related]
6. 4-Kallikrein Test and Kallikrein Markers in Prostate Cancer Screening.
McDonald ML; Parsons JK
Urol Clin North Am; 2016 Feb; 43(1):39-46. PubMed ID: 26614027
[TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid carcinoma of the prostate with adenocarcinoma, squamous cell carcinoma, and heterologous components.
Acosta AM; Senseng C; Kim G; Sekosan M; Ree N
APMIS; 2016 Aug; 124(8):719-22. PubMed ID: 27197712
[No Abstract] [Full Text] [Related]
8. Prostate Health Index (PHI): golden bullet or just another prostate cancer marker?
Loeb S
Eur Urol; 2013 Jun; 63(6):995-6; discussion 996-7. PubMed ID: 23453055
[No Abstract] [Full Text] [Related]
9. Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
Meyers FJ; DeVere White RW
West J Med; 1998 Jun; 168(6):525. PubMed ID: 9655997
[No Abstract] [Full Text] [Related]
10. Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.
Taneja SS
J Urol; 2015 Jan; 193(1):127. PubMed ID: 25523657
[No Abstract] [Full Text] [Related]
11. Etiology and diagnosis of prostate cancer: what's new? A review.
Zlotta AR; Schulman CC
Eur Urol; 1998; 33(4):351-8. PubMed ID: 9612676
[No Abstract] [Full Text] [Related]
12. Valentine's Day PSA.
Dasgupta P
BJU Int; 2014 Feb; 113(2):177. PubMed ID: 24712694
[No Abstract] [Full Text] [Related]
13. Prostate specific antigen testing: age-related interpretation in early prostate cancer detection.
McKenzie PR; Delahunt B; Kench JG; Ross B; Lam Q; deVoss K; Tran HA; Sikaris KA
Pathology; 2013 Jun; 45(4):343-5. PubMed ID: 23619589
[No Abstract] [Full Text] [Related]
14. Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!
Collette L; Buyse M; Burzykowski T
J Clin Oncol; 2007 Dec; 25(35):5673-4; author reply 5674. PubMed ID: 18065747
[No Abstract] [Full Text] [Related]
15. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].
Medvedev VL
Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295
[No Abstract] [Full Text] [Related]
16. Prostate cancer: Personalized risk - stratified screening or abandoning it altogether?
Carlsson SV; Kattan MW
Nat Rev Clin Oncol; 2016 Mar; 13(3):140-2. PubMed ID: 26831183
[No Abstract] [Full Text] [Related]
17. [Utility of prostate-specific antigen in pleural fluid for the diagnosis of metastatic effusion secondary to prostate cancer].
Sánchez Merino JM; Quintana González JI; Toribio Sánchez CM; Gómez Cisneros SC; Parra Muntaner L; García Alonso J
Actas Urol Esp; 2002; 26(7):513-4. PubMed ID: 12224436
[TBL] [Abstract][Full Text] [Related]
18. High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse.
Rabien A; Fritzsche F; Jung M; Diamandis EP; Loening SA; Dietel M; Jung K; Stephan C; Kristiansen G
Tumour Biol; 2008; 29(1):1-8. PubMed ID: 18497543
[TBL] [Abstract][Full Text] [Related]
19. Prostate adenocarcinoma presenting with supraclavicular node enlargement: report of a case.
Platania M; Bajetta E; Guadalupi V; Buzzoni R; Colecchia M
Tumori; 2008; 94(5):769-71. PubMed ID: 19112959
[TBL] [Abstract][Full Text] [Related]
20. [German Cancer Society e.V. S3 guideline for PSA determination in diagnosis of prostatic carcinoma].
Rübben H; Schalkhäuser K; Wolff J; Luboldt HJ;
Onkologie; 2003 Feb; 26(1):88-9. PubMed ID: 12661558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
